TD Securities initiated coverage of Healwell AI (HWAIF) with a Buy rating and C$1.75 price target The firm believes shares are poised to continue the rebound from their recent 52-week low as Healwell benefits from its strengthened competitive position with the “transformational” Orion acquisition, adding that it expects increased cross-selling wins to drive stronger organic growth and margin expansion.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HWAIF:
- Healwell AI price target lowered to C$2.50 from C$3 at Raymond James
- Healwell AI price target lowered to C$2.50 from C$3.10 at Stifel
- HEALWELL AI: Buy Rating Backed by Profitable Shift to High‑Margin AI/SaaS and Strong Earnings Momentum
- HEALWELL AI Posts Record Revenue and Turns Adjusted EBITDA Positive as It Becomes Pure-Play AI Software Firm
- MCI Onehealth Technologies, Inc. Class A (AIDX) Q4 Earnings Cheat Sheet